The report “Urology Devices Market by Product ((Endoscopes, Robotic, Lasers & Lithotripsy, Dialysis, Urodynamic Systems), (Guidewires, Catheters, Biopsy Devices)), Disease (Kidney Disease, Urologic Cancer, Pelvic Organ Prolapse), End User – Global Forecast to 2022”, The urology devices market is expected to reach USD 44.37 Billion by 2022 from USD 31.44 Billion in 2017, at a CAGR of 7.1%. Factors driving the growth of this market include the growing geriatric population, rising incidence of cancer, increasing healthcare expenditure, and technological advancements in urology devices.
Download PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212
Instruments are estimated to account for the largest share of the market in 2017
By product, the urology devices market is classified into instruments and consumables & accessories. The instruments segment is expected to lead the global urology devices market in 2017. Factors driving the growth of this segment include increasing adoption of urology devices in hospitals and clinics, rising incidence of chronic disorders, and increasing demand for minimally invasive surgeries in urology.
The kidney diseases segment is expected to dominate the market in 2017
By disease, the market is segmented into kidney disease, urological cancer and BPH, pelvic organ prolapse. The kidney diseases segment is expected to account for the largest share of the global urology devices in 2017. A large number of products are used in the diagnosis and treatment of this segment which is a major factor responsible for the dominant share of this segment.
Hospitals and clinics are estimated to command the largest share of the market during the forecast period
On the basis of end user, the urology devices market is categorized into hospitals and clinics, dialysis centers, and other end users. The hospitals and clinics segment is estimated to account for the largest share of the global urology devices market during the forecast period. The heavy burden of urological cancers such as prostate cancer and bladder cancer, along with the accessibility and availability of diagnosis and treatment instruments in hospitals and clinics in a short period of time are the key factors driving the growth of this end-user segment.
North America is estimated to command the largest share of the market
Based on region, the urology devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to dominate the urology devices market in 2017. This is attributed to factors such as accessibility to advanced technologies and opportunities for advanced cancer diagnostic testing and screening, growing incidence of cancer, and technological advancements of urology devices in the region as compared to other regions.
Key players in the urology devices market include Fresenius Medical Care (Germany), Baxter (US), Boston Scientific (US), Olympus (Japan), Richard Wolf (US), KARL STORZ (Germany), Cook Medical (US), Medtronic (US), C. R. Bard (US), Dornier MedTech (Germany), Prometheus Group (US), Medi-Globe (US), Intuitive Surgical (US), Merit Medical Systems (US), Siemens Healthcare (Germany), Stryker (US), ROCAMED (France), Medica (Italy), NOVAmedtek (Turkey), SRS Medical Systems (US), ProSurg (US), Albyn Medical (UK), EMD Medical Technologies (Canada), and Biolitec (Germany).